
November 21, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector equities ran the gauntlet through the forest of sentiment increasing its distance to conviction
November 21, 2024
RegMed Investors’ (RMi) pre-open: lack of expectation as depreciated share pricing realities set-in
November 20, 2024
RegMed Investors (RMi) Closing Bell: sector equities keep getting cheaper
November 20, 2024
RegMed Investors’ (RMi) pre-open: get some more
November 19, 2024
RegMed Investors (RMi) Closing Bell: green on the screen; yet, there is still red in the portfolio
November 19, 2024
RegMed Investors’ (RMi) pre-open: BUY some!
November 18, 2024
RegMed Investors (RMi) Closing Bell: Buy-into sector after political “concerns” spool value downward
November 18, 2024
RegMed Investors’ (RMi) pre-open: down so long, time for an upside flip
November 15, 2024
RegMed Investors (RMi) Closing Bell: another wipe-out of value
November 15, 2024
RegMed Investors’ (RMi) pre-open: investors feel the pain
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors